Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients. With 24 manufacturing sites and 3 R&D centers in Europe, North America and Asia, SEQENS develops custom solutions and ingredients for the most demanding industries such as healthcare, electronics, cosmetics, food and homecare. Driven by a culture of excellence and a strong entrepreneurial spirit, SEQENS' 3,200 employees are committed to providing its customers with the highest level of service and product quality while acting ethically in alignment with our Corporate Social Responsibility program.
View Top Employees from Novacap| Website | http://seqens.com |
| Revenue | $1.08 billion |
| Employees | View employees |
| Address | 9 Opportunity Way, Newburyport, Massachusetts 01950, US |
| Phone | (978) 462-5555 |
| Fax | (978) 465-2057 |
| Industry | Chemicals, Chemicals, Petrochemicals, Glass & Gases, Manufacturing |
| Competitors | Aurobindo Pharma, Laurus Labs Limited, PHARMACEUTICAL MANAGEMENT SERVICES LIMITED, ScinoPharm Taiwan Ltd, Siegfried Holding AG |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Novacap employee's phone or email?
Novacap Questions
The Novacap annual revenue was $1.08 billion in 2023.
Novacap is based in Newburyport, Massachusetts.
The NAICS codes for Novacap are [32, 32541, 325, 3254].
The SIC codes for Novacap are [283, 28].
